Erasca Statistics
NASDAQ: ERASHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.12-0.18 (-1.26%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 14.12 0.00%
Erasca by the numbers
Erasca has a market capitalization of $4.94 billion based on 349.76M shares outstanding. With trailing EPS of $-0.95, Erasca is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.6% below its 50-day average and 0.2% above its 200-day average.
Average daily trading volume is 4.32M shares, or about $60.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ERAS valuation vs. peer median
| Metric | ERAS | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.94B | $5.07B | -3% |
| Avg. volume | 4.32M | 985.73K | +338% |
Peer median across 8 companies: TVTX, GRFS, COGT, MIRM, DNTH, PTCT, MANE, EWTX.
Valuation
- Market cap
- $4.94B
- EPS (TTM)
- $-0.95
- Shares outstanding
- 349.76M
Price and trading
- Previous close
- 14.30
- Open
- 14.13
- Day range
- 13.93 – 14.57
- 52-week range
- 2.11 – 24.28
- 52-week change
- +470.56%
- Beta
- —
- Volume
- 3.83M
- Average volume
- 4.32M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 4.94B
- Forward Pe
- -22.66
- Eps
- -0.95
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 24.28
- Week52 Low
- 2.11
- Avg Volume
- 4.32M
- Shares Outstanding
- 349.76M
- Ma50
- 16.73
- Ma200
- 14.09
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -41.85%
- Pct From52w Low
- 570.78%